Italy – Cleaning and sanitation services – APPALTO SERVIZI DI PULIZIA DEGLI UFFICI DEGLI ORGANISMI DELLA POLIZIA DI STATO DI CATANZARO E PROVINCIA DURATA TRIENNALE

Italy – Refuse recycling services – Procedura Aperta, suddivisa in 2 (due) Lotti, per l'affidamento del servizio di trattamento e recupero dei rifiuti in legno provenienti dai centri di raccolta di AMA S.p.A., dal servizio di raccolta differenziata tramite noleggio cassoni c/o le grandi utenze, dalle operazioni di rimozione rifiuti e/o dalle richieste di viaggi a pagamento, conferiti da AMA S.p.A. e/o per conto di AMA S.p.A., per un

Italy – Building-cleaning services – PROCEDURA APERTA, SUDDIVISA IN TRE LOTTI, PER L’AFFIDAMENTO TRIENNALE DEI SERVIZI INTEGRATI PRESSO LE SEZIONI DELL’ISTITUTO NAZIONALE DI GEOFISICA E VULCANOLOGIA (INGV): LOTTO 1_ SEZIONE DI NAPOLI (SEDI DI NAPOLI: OSSERVATORIO VESUVIANO-Via DIOCLEZIANO E SEDE di ERCOLANO); LOTTO 2_SEZIONE DI CATANIA – OSSERVATORIO ETNEO; LOTTO 3_SEZIONE IRPINIA

Italy – Cleaning and sanitation services – Servizi di pulizia, sanificazione ambientale e prestazioni accessorie a ridotto impatto ambientale presso gli stabili del "Polo Tuscolano" siti in Roma

Italy – Refuse disposal and treatment – SERVIZIO GESTIONE DEI RIFIUTI SPECIALI PERICOLOSI E NON E PER I SERVIZI ECOLOGICI DEL CENTRO RICERCHE DELLA CASACCIA E DELLA SEDE LEGALE ENEA

Italy – Snow-clearing services – PROCEDURA APERTA AI SENSI DELL’ARTICOLO 71 DEL D.LGS. N. 36/2023 PER L’AFFIDAMENTO DEL SERVIZIO DI SGOMBERO NEVE, TRATTAMENTO ANTIGHIACCIO E MANTENIMENTO DELLA VIABILITA’ COMUNALE PER LE STAGIONI INVERNALI 2026/2027 - 2027/2028 – 2028/2029 IN COMUNE DI VALFURVA.

Established by Congress in fiscal year (FY) 1997, the Habitat Conservation Plan (HCP) Land Acquisition Grant program was designed to reduce conflicts between the conservation of listed species and competing land uses on specific parcels of land associated with approved and permitted HCPs. Under this program, the U.S. Fish and Wildlife Service (FWS) provides matching grants to State agencies in support of land acquisition projects that will conserve species habitat in perpetuity through fee simple acquisition or the acquisition of permanent conservation easements. FWS considers the use of Federal acquisition dollars by States for habitat protection associated with HCPs to be an important and effective mechanism to promote species recovery, prevent extinction, and preclude the need to list species under the Endangered Species Act (ESA) in the future. All land acquired through these grants complements, but does not replace, the mitigation, minimization, and/or monitoring commitments of the HCP. Thus, this work is additive to the conservation commitments entered into when HCPs are permitted and serves as a meaningful way to leverage non-Federal investment in species recovery and connect conservation lands across the landscape.

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e., botanicals, probiotics, and products marketed as dietary supplements), which have a strong scientific premise to justify further clinical testing. For this NOFO, natural products include promising nutritional regimens that standardize the amount of a specific naturally occurring nutritional compound (e.g., omega-3 fatty acids, anthocyanidins, or polyphenols) and have compelling preliminary evidence. Under this NOFO, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support decisions about further development or testing of the natural product. This NOFO will provide up to three years (R61 phase) of support for milestone-driven testing of pharmacokinetics, bioavailability, and assessment of the natural products effect (i.e., measure of mechanism of action) when used by humans on a specified target measure. If milestones in the R61 phase are achieved, up to 3 years of additional support (R33 phase) may be awarded to replicate the impact of the natural product on target engagement(s) when used by humans and assess whether there is an association between the degree of the impact on the target engagement and clinical outcomes in a participant population. Applications are encouraged to design R33 studies to determine how to optimize the impact of the natural product on the target engagement by optimizing the delivery of the natural product through examination of different doses or formulations. In addition, applications can be designed to combine the natural product with another treatment approach that is known to impact the same target engagement measure; or study the impact of the natural product in a population that is more responsive,

The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. This Notice of Funding Opportunity is intended to stimulate the development and testing of highly innovative experimental or computational approaches for rare disease diagnosis, that have the potential to make transformative improvements to the current state of the art.

The American Institute in Taiwan Public Diplomacy Section announces an open competition for one cooperative agreement to support the implementation of four Global Cooperation and Training Framework Classic workshops in Taiwan during calendar year 2027. The GCTF is a capacity building platform that brings together government officials, industry experts, academics, and civil society representatives to exchange practical experience and promote professional cooperation on emerging regional and global challenges. Workshop topics will be jointly identified by GCTF partners and may address resilience, emerging technologies, economic security, trusted supply chains, democratic governance, and other shared priorities. The selected recipient will serve as the implementation partner responsible for comprehensive operational and administrative support, including venue coordination, participant registration, international travel support, interpretation, audiovisual services, workshop materials, vendor coordination, site visits, monitoring and evaluation, and required grant reporting. Most workshops are expected to take place in Taipei, with one anticipated in southern Taiwan. AIT and GCTF partners will provide policy guidance, strategic direction, and substantive oversight. The project is intended to strengthen international cooperation, promote policy dialogue and capacity building, improve continuity across GCTF programming, and advance practical exchanges among government, industry, academia, and civil society.

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data. Applicants are encouraged to leverage and perform innovative analyses of the existing data. Applications may include new research aims that are being addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that allow the exploration of important scientific questions in cancer research.